Literature DB >> 3026562

Increased corticotropin-releasing factor receptors in rat cerebral cortex following chronic atropine treatment.

E B De Souza, G Battaglia.   

Abstract

Rats were treated chronically with atropine (14 days, 20 mg/kg/day, s.c.) and corticotropin-releasing factor (CRF) receptors and CRF-mediated adenylate cyclase activity were measured in discrete brain regions. Chronic atropine treatment produced significant increases in muscarinic cholinergic receptors in the frontoparietal cortex (30% increase) and hippocampus (20% increase). No significant changes in the concentration of [125I]Tyr0-rat CRF binding sites were observed in olfactory bulb, cerebellum, striatum and hippocampus. In contrast, there was a significant and selective increase (35%) in CRF receptors in the frontoparietal cortex of atropine-treated rats. However, no significant corresponding changes in the Vmax or EC50 of CRF-stimulated adenylate cyclase activity accompanied the upregulation of CRF receptors in the cerebral cortex. These results demonstrate that CRF receptors in rat brain are subject to receptor regulation, the upregulation of CRF receptors occurs as a consequence of chronic muscarinic cholinergic receptor blockade, and this interaction between acetylcholine and CRF may be limited to the cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026562     DOI: 10.1016/0006-8993(86)90647-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Effect of acute and chronic diisopropylfluorophosphate and atropine administration on somatostatin binding in the rat frontoparietal cortex and hippocampus.

Authors:  I A Alonso; J C Prieto; E Arilla
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 2.  Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.

Authors:  H Lehnert; C Schulz; K Dieterich
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

3.  Effects of atropine treatment on in vitro and in vivo binding of 4-[125I]-dexetimide to central and myocardial muscarinic receptors.

Authors:  Y Uno; K Matsumura; U Scheffel; A A Wilson; R F Dannals; H N Wagner
Journal:  Eur J Nucl Med       Date:  1991
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.